Evidence-Based Drug Policy Act of 2025
Sponsored By: Representative Titus, Dina [D-NV-1]
Introduced
Summary
Repeals Section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(b)(12)). This is a housekeeping repeal that only removes that specific statutory subsection without adding other policy or funding changes.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Repeal a rule for federal drug office
This bill would repeal one subsection of the law that guides the federal drug policy office in the White House. It would not add new programs, funding, or replacement rules. The text does not set an effective date. Any real-world effect would depend on what that removed subsection required or limited, so most households would not see direct changes.
Sponsors & CoSponsors
Sponsor
Titus, Dina [D-NV-1]
NV • D
Cosponsors
Rep. Omar, Ilhan [D-MN-5]
MN • D
Sponsored 4/29/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov